Induction of HLA class I antigens on cultured melanoma cells FO-1 after transfection with a human or a mouse B2m gene was associated with a statistically significant reduction in their susceptibility to natural killer (NK) cell-mediated lysis. These results indicate that the structural differences between human and mouse 62-M do not abolish the ability of the HLA class I molecular complex to modulate NK cell-mediated lysis ofmelanoma cells FO-1. The role of HLA class I antigens in the phenomenon is corroborated by the ability of anti-HLA class I MAb to enhance, although to a different extent, the susceptibility of transfected FO-1 cells to NK cell-mediated lysis. Gamma interferon (IFN-'y) and tumor necrosis factor-a (TNF-a) significantly reduced the susceptibility to NK cell-mediated lysis of transfected FO-1 cells. Surprisingly, TNF-a reduced the extent of lysis more than IFN-'y, although the latter cytokine enhanced HLA class I antigen expression more than the former one. This finding, in conjunction with a reduction in the susceptibility to NK cell-mediated lysis of untransfected FO-1 cells incubated with IFN-'y or TNF-a, suggests that the two cytokines reduce NK cell-mediated lysis of transfected cells by modulating not only the expression of HLA class I antigens, but also that of other structures. Induction of HLA class I antigens and their modulation with IFN-'y did not affect the susceptibility to lymphokine-activated killer (LAK) cell-mediated lysis of transfected FO-1 cells. Characterization of the molecular mechanism(s) underlying abnormalities in HLA class I antigen expression by melanoma cells and of the role of these molecules in the interactions of melanoma cells with various types of effector cells may suggest novel immunotherapeutic approaches to melanoma. (J. Clin. Invest. 1991. 88:282-289.) 
Introduction
Malignant transformation of melanocytes may be associated with changes in HLA class I antigen expression (for review, see reference 1). These changes may have clinical relevance, be-cause a statistically significant, although not absolute, association has been found between levels of HLA class I antigen expression in melanoma lesions and clinical course of the disease (2). The mechanism underlying this phenomenon is not known but is ofgreat interest, because its characterization may contribute to our understanding of the role of HLA class I antigens in the biology of melanoma cells and in their interactions with host's immune system. This information may eventually suggest novel therapeutic approaches to melanoma.
Besides their role as restricting elements in the lysis oftarget cells by cytotoxic T cells (3), HLA class I antigens have been shown to regulate susceptibility to natural killer (NK)' cellmediated lysis of tumor cells in some, although not all, the systems investigated (for review, see reference 4). Scanty and conflicting information is available about the role ofHLA class I antigens in NK cell-mediated lysis of melanoma cells. To the best ofour knowledge, only Lobo and Spencer (5) and Versteeg et al. (6) have investigated this phenomenon. Lobo and Spencer (5) have reported that cultured melanoma cells SK-MEL-l are particularly resistant to NK cell-mediated lysis; at variance with results obtained with other cell lines, anti-HLA class I MAb did not increase the extent of NK cell-mediated lysis. Versteeg et al. (6) have shown that a spontaneous HLA class I negative variant isolated from the melanoma cell line 51 8A after long time culturing and the melanoma cells IGR30 with a reduced HLA class I antigen expression after transfection with the c-myc oncogene display an increased susceptibility to NK cell-mediated lysis. Although suggestive, these results do not prove a cause-effect relationship between reduction in HLA class I antigen expression and increased susceptibility to NK cell-mediated lysis of melanoma cells IGR30 and 518A, because prolonged in vitro culturing or transfection with c-myc oncogene may modify the expression of unrelated antigenic structures which modulate susceptibility to NK cell-mediated lysis. Furthermore, the results obtained with most ofthe tumor systems investigated might not be valid for melanoma cells, because the latter express molecules, such as HLA class II antigens and intercellular adhesion molecule-1 (ICAM-1) (7, 8) , which may play a role in the interaction ofNK cells with target cells (5; Maio, M., and S. Ferrone, unpublished results). Therefore, to eliminate the potential interference of antigens in NK cell-mediated lysis of melanoma cells, in the present study, we have characterized the effect ofthe induction of HLA class I antigens on the susceptibility to NK cell-mediated lysis ofmelanoma cells FO-I which do not express HLA class I antigens because of a structural defect in B2m gene (9, 10) . Furthermore, because NK cell-mediated lysis of human tumor cells cannot be modulated by H-2 class I heavy chains associated with human 32-microglobulin (#2-is) ( 1 1), we have compared the susceptibility to NK cell-mediated lysis of FOcells transfected with a human and a mouse B2m gene to determine the effect of differences in #2-' structure (12) (13) (14) on the lytic phenomenon.
Methods
Cells. The melanoma cell line Colo 38, the melanoma cell line FO-l (9), and the cell line FO-IC transfected with a mouse B2m gene (10) were grown in RPMI 1640 medium (Flow Laboratories Inc., McLean, VA) supplemented with 10% heat-inactivated FCS (Flow Laboratories Inc.) and 2 mM L-glutamine.
Peripheral blood mononuclear cells (PBMC) were separated from heparinized blood of healthy volunteers by Ficoll-Hypaque (Pharmacia Fine Chemicals AB, Uppsala, Sweden) density gradient centrifugation (400 g for 30 min). After three washings with HBSS (Flow Laboratories Inc.), they were used either as a source ofNK cells or for lymphokine activated killer (LAK) cell generation. The latter were generated by culturing PBMC in the continuous presence of interleukin-2 (IL-2) (1,000 U/ml) for at least 10 d; halfofthe medium was changed every 48 h with an equal volume offresh medium containing IL-2. At the end of the culture more than 95% of cells were stained by anti-CD3 MAb OKT3 in indirect immunofluorescence (IIF). The functional activity of LAK cell preparations was monitored by testing their ability to lyse the NK cell-resistant cultured melanoma cells Colo 38.
Human B2m gene. Human /2-M clone p#2m 13 in the vector pEMBL9 (14) was purified on a CsCI gradient cushion and linearized with the restriction enzyme Sal I before transfection.
MAb and conventional antisera. The MAb W6/32, TP25.99. 1, and CR1 1-1 15 to distinct monomorphic determinants of HLA class I antigens, the MAb Q6/64 and H2-89-1 to determinants restricted to the gene products of the HLA-B locus, the anti-(12-M MAb NAMB-1, the anti-HLA-DR, DQ, DP MAb Q5/13 and the anti-ICAM-l MAb CL203.4 were developed and characterized as described elsewhere (15) (16) (17) (18) (19) (20) . Anti-CD3 MAb OKT3 was purchased from Ortho Diagnostic Systems (Milan, Italy). MAb were purified from ascitic fluid by sequential precipitation with caprylic acid and with ammonium sulfate (21) . F(ab')2 fragments were prepared by incubating purified immunoglobulins (5 mg/ml) in 100 mM sodium citrate (pH 3.5) with 25 mg ofpepsin (Sigma Chemical Co., St. Louis, MO) for 18 h at 370C. Digestion was stopped by adding 1/1o volume of 3 M Tris buffer (pH 8.8). Samples were then extensively dialyzed against PBS, pH 7.2. The purity ofMAb and F(ab')2 fragment preparations was monitored by SDS-PAGE (22) under reducing and nonreducing conditions. The activity of purified MAb and F(ab')2 fragment preparations was monitored by IIF staining of target cells. One-dimensional SDS-PAGE was performed on 10% polyacrylamide slab gels under reducing conditions using the buffer system described by Laemmli (22) . Gels were processed for autoradiography using a Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY).
Cytotoxicity assays. All experiments were performed in triplicates in round bottom microtiter plates (Costar, Cambridge, MA). Target cells (2 x 106) were resuspended in 1 ml ofRPMI 1640 medium supplemented with 20% FCS and incubated with 200 MCi of Na25`CrO4 Modulation by IFN-y and TNF-at ofHLA class I antigen expression by melanoma cells FO-1, FO-i C, and FO-iH. Incubation for 42 h with IFN-'y (1,000 U/ml) ( Fig. 1 B) and TNF-a (1,000 U/ml) ( Table I , the level of NK cell-mediated lysis of FO-l cells was significantly higher than that of FO-1 H cells at all the effector/target cell ratios tested and significantly higher than that of FO-lC cells only at the effector/target cell ratios of 100:1 and 50:1. Furthermore, the extent ofNK cell-mediated lysis ofFO-I H cells was significantly lower than that of FO-lC cells at all the effector/target cell ratios tested, but that of 12.5:1. (Table II) . Effect ofIFN-'y and TNF-a treatment on the susceptibility ofFO-J, FO with IFN--y (1,000 U/ml) or with TNF-a (1,000 U/ml). Cells incubated under the same experimental conditions, but not exposed to cytokines were used as controls. At the end of the incubation, cells were washed, labeled with 5"Cr, and incubated at 370C for 4 h with PBMC from six donors of the effector/target cell ratio of 50:1. The supernatant was then harvested and released radioactivity was measured in a y-counter. Data are expressed as the mean ± SD of the percentage of specific 5"Cr release obtained in six experiments. The susceptibility of FO-l cells to NK cell-mediated lysis was significantly reduced after induction of HLA class I antigen expression by transfection with a human or a mouse B2m gene. The significant reduction in the susceptibility to NK cellmediated lysis ofFO-I cells transfected with a mouse B2m gene is noteworthy, because it shows that the structural differences between human and mouse 62-es (12) (13) (14) do not abolish the ability of the HLA class I molecular complex to reduce the susceptibility to NK cell-mediated lysis of FO-l melanoma cells. On the other hand, replacement of HLA class I heavy chain with the mouse counterpart is associated with the loss of the ability to modulate NK cell-mediated lysis of a cultured lymphoid cell line (1 1). These results altogether strongly suggest that the heavy chain ofthe HLA class I molecular complex plays the major role in the modulation of NK cell-mediated lysis of tumor cells. The increase induced by anti-HLA class I MAb in NK cellmediated lysis ofFO-lC and FO-lH cells corroborates the role of HLA class I antigens in this phenomenon. Furthermore, the lack of effect of anti-HLA class I MAb on NK cell-mediated lysis of untransfected FO-l cells indicates that they modulate the extent of lysis by interacting with the target cells and not with the effector cells. The latter conclusion is in agreement with data by Sturmhofel and Hammerling (26) . An anti-H-2 class I MAb did not affect the NK cell-mediated lysis of a variant of mouse thymoma EL4 cells which does not express H-2 class I antigens, but enhanced that of the cells which had acquired H-2 class I antigens after transfection with a mouse B2m gene.
The differential susceptibility to NK cell-mediated lysis of FO-lC and FO-lH cells suggests a relationship between extent ofNK cell-mediated lysis oftumor cells and their level ofHLA class I antigen expression. This possibility is supported by the (33) suggestion that the extent of NK cell-mediated lysis is correlated to HLA class I antigen expression only within certain ranges of expression. No significant change is detected in the extent of NK cell-mediated lysis, when HLA class I antigen expression is below a threshold level or above a plateau level.
The increase in NK cell-mediated lysis of melanoma cells induced by anti-HLA class I MAb parallels similar results obtained with human T cell lymphomas, breast carcinoma cells (34) and lung small cell carcinomas (5) and with mouse thymoma cells (26) . On the other hand, these results are at variance with the lack of effect of anti-MHC class I antibodies on the NK cell-mediated lysis ofhuman (5) and mouse (35) melanoma cells and of human lymphoblastoid cells (27) . Furthermore, our results differ from those in the literature in two aspects; in Lobo and Spencer's (5) experiments, only target cells which do not express HLA class II antigens were susceptible to increase in NK cell-mediated lysis by anti-HLA class I antibodies, whereas in our studies, the phenomenon was observed with a melanoma cell line which expresses HLA (34) , the whole IgG of the anti-HLA class I MNAb tested enhanced the extent of NK cellmediated lysis, whereas the F(ab')2 fragments did not, therefore suggesting that the increase mediated by anti-HLA class I MAb may reflect an ADCC phenomenon. On the other hand, in our experiments, the whole IgG of anti-HLA class I MAb were as effective as F(ab')2 fragments in enhancing NK cell-mediated lysis of melanoma cells FO-lC and FO-lH. Whether the conflicting results reflect differences in the characteristics of the MAb tested and/or in the antigenic profile of the cells used as targets in the two studies remains to be determined. In agreement with the results obtained by Lobo and Spencer (5) who utilized cultured lymphoid cells as targets, we have found a differential effect of MAb to distinct monomorphic determinants of HLA class I antigens on NK cell-mediated lysis of melanoma cells. This finding does not appear to correlate with the affinity constants ofthe MAb tested and/or with the level of expression of the corresponding determinants on target cells. On the other hand, the mapping to the al/2 domains of HLA class I heavy chains of the epitope(s) required for protection against NK cell-mediated lysis (33) suggests that the differential effect ofthe anti-HLA class I MAb tested may reflect differences in the distribution ofthe corresponding determinants on the three domains of HLA class I heavy chains. In this regard, testing with mouse cells transfected with H2/HLA class I hybrid genes has shown that the determinant recognized by MAb H2-89-1 with the strongest modulatory effect is expressed on the a2 domain, whereas that recognized by MAb CR1 1-1 15 with no detectable effect is expressed on the a2 and a3 domain (Takiguchi, M., and S. Ferrone, unpublished results).
The results with IFN-y or TNF-a-treated melanoma cells deserve some comments, because they may suggest some explanations for the conflicting information about the effect ofcytokines on NK cell-mediated lysis of tumor cells. Although not statistically significant, the reduction in the susceptibility to NK cell-mediated lysis of FO-l cells after incubation with IFN-y or TNF-a suggests that the two cytokines modulate the expression not only of HLA class I antigens but also of other structures which are involved in the phenomenon. The role of the latter structures which will be referred to as non-HLA-NK cytolysis related structures is also suggested by the more marked effect of TNF-a than of IFN-'y on NK cell-mediated lysis of melanoma cells FO-lH, although the latter cytokine enhances HLA class I antigen expression more than the former one. In addition, these results suggest that the non-HLA-NK cytolysis related structures are more susceptible to modulation by TNF-a than by IFN-y. A precedent for the latter possibility is represented by the higher susceptibility ofICAM-1 to modulation by TNF-a than by IFN-'y (36). The differential expression of the non-HLA-NK cytolysis related structures and of HLA class I antigens may account for the conflicting data about the effect of IFN-'y on NK cell-mediated lysis ofvarious types ofhuman tumor cells (37) (38) (39) (40) (41) (42) (43) (44) . Furthermore, the modulation of the non-HLA-NK cytolysis-related structures may account for the reduction in the susceptibility to NK cell-mediated lysis oftumor cells after incubation with IFN-y, but not after transfection with HLA class I genes, although the two approaches induce similar levels of HLA class I antigens (43, 45) . The reduction in the susceptibility to NK cell-mediated lysis of FO-1 cells after incubation with IFN-y is similar to the slight decrease in NK cell-mediated lysis of a cultured B lymphoblastoid cell line after incubation with IFN-y, although the low HLA class I antigen expression did not change (37) . These results are at variance with the lack of effect of IFN-'y on the NK cell-mediated lysis of variants of the mouse cell lines EL4 (26) and YAC (46) 
